Altimmune (ALT) announced the expansion of its Board of Directors with the appointments of Teri Lawver and Jerry Durso. Lawver is most recently served as Executive Vice President and Chief Commercial Officer at Dexcom (DXCM). Durso most recently served as CEO and a member of the Board of Directors of Intercept (ICPT) Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT: